50 employees
Scinai Immunotherapeutics is an innovative biopharmaceutical company.
2003
$22M
from 2 investors over 2 rounds
BiondVax raised $22M on June 19, 2017
Investors: European Investment Bank
BiondVax raised $1.3M on September 9, 2014
Investors: MATIMOP - The Israeli Industry Center for R&D